Related Experiment Video
Updated: Oct 25, 2025

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets
Martina Rossi1, Kotb Abdelmohsen1
1Laboratory of Genetics and Genomics, RNA Regulation Section, National Institute on Aging Intramural Research Program, National Institutes of Health, 251 Bayview Blvd., Baltimore, MD 21224, USA.
Abstract:
Senescence is linked to a wide range of age-associated diseases and physiological declines. Thus, senotherapeutics are emerging to suppress the detrimental effects of senescence either by senomorphics or senolytics. Senomorphics suppress the traits associated with senescence phenotypes, while senolytics aim to clear senescent cells by suppressing their survival and enhancing the apoptotic pathways. The main goal of these approaches is to suppress the proinflammatory senescence-associated secretory phenotype (SASP) and to promote the immune recognition and elimination of senescent cells. One increasingly attractive approach is the targeting of molecules or proteins specifically present on the surface of senescent cells. These proteins may play roles in the maintenance and survival of senescent cells and hence can be targeted for senolysis. In this review, we summarize the recent knowledge regarding senolysis with a focus on novel surface biomarkers of cellular senescence and discuss their emergence as senotherapeutic targets.
Insights
Senotherapeutics offer new ways to combat aging by targeting senescent cells. This review focuses on senolysis, using surface biomarkers to eliminate these cells and treat age-related diseases.
Area of Science:
- Gerontology and Cellular Biology
- Biomedical Sciences
- Molecular Biology
Background:
- Cellular senescence contributes to age-associated diseases and physiological decline.
- Senotherapeutics, including senomorphics and senolytics, aim to mitigate these effects.
- Senolytics target senescent cells for clearance, reducing inflammation and promoting immune removal.
Purpose of the Study:
- To review current knowledge on senolysis, a strategy to eliminate senescent cells.
- To highlight novel surface biomarkers of cellular senescence.
- To discuss the potential of these biomarkers as targets for senotherapeutics.
Main Methods:
- Literature review of recent research on senolysis and cellular senescence.
- Focus on identifying and analyzing surface biomarkers specific to senescent cells.
- Discussion of the therapeutic implications of targeting these biomarkers.
Main Results:
- Senescent cells exhibit unique surface proteins crucial for their survival.
- These surface proteins represent promising targets for senolytic drugs.
- Targeting surface biomarkers can enhance the selective elimination of senescent cells.
Conclusions:
- Targeting surface biomarkers is a viable senotherapeutic strategy.
- Further research into these biomarkers could lead to effective treatments for age-related conditions.
- Senolysis via surface biomarker targeting holds significant promise for improving healthspan.
Related Concept Videos
Replicative Cell Senescence
Targeted Cancer Therapies
There are several types of targeted therapies against...
Renewal of Skin Epidermal Stem Cells

